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Abstract: Prolactin hormone is a polypeptide involved in the differenciation of normal mammary epithelium. 
Prolactin hormone has 200 amino acids, and it prepares  the physiology of women for lactation and maternal 
care. Though, it is more important for the onset rather than the maintenance of maternal care. It exhibits a 
circadian variation whereby it is higher in the evenings. Previous scientific reports  stated that Prolactin levels 
are higher in nulliparous women than in parous women, due to the fact that early first full term pregnancy 
causes a lowering of  the level of  circulating prolactin hormone. Hyperprolactinemia (abnormally high levels of 
prolactin) is a contributing factor to both female and male infertility. Especially cases of primary infertility. 
This present study was carried out to investigate the frequency of the prolactin  levels among the infertile female 
patients in National hospital Abuja, and to analyse the difference in the prolactin levels between those suffering 
from primary infertility and those suffering from secondary infertility. The prolactin levels among female 
patients suffering primary infertility and secondary infertility were studied respectively and compared to the 
normal range of prolactin levels in nulliparous women. The prolactin levels of patients suffering primary 
infertility and secondary infertility were also compared. The result of this study suggested that a prolactin 
hormone abnormality was not a major contributory factor to the infertility problem suffered by most Female 
Infertility patients in National Hospital Abuja. 
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I. Introduction 
Nigeria is made up of about over 250 ethnic groups with different traditions and customs, but have a 
similar perspective on fertility, and like most other African countries, high fertility and large families are valued 
in Nigeria. In most African traditions, fertility is seen as a blessing of the gods. Therefore anyone who is 
infertile is considered to be cursed and women tend to bear the brunt of the social stigma because their role in 
marriage is to give birth to children. Hence, even in modern times, they are the first to seek medical attention. 
The fertility transition in Nigeria as indicated in the Nigeria Fertility Survey (NFS) showed a Total Fertility Rate 
(TFR) of 5.94 in 1980-1982, and the 1990 Nigeria Demographic and Health Survey put the TFR at 6.01 in the 
period of 1988-1990. Further decline in TFR was indicated for 1992-1994 by a 1994 sentinel survey as 5.4, and 
for 1995-1999 by the 1999 Demographic and Health Survey as 5.2. ( 13). Infertility has gradually become an 
issue in Nigeria, but then, most people confuse infertility with sterility and sub-fertility. However, about 30% of 
all female infertility is caused by a hormonal imbalance of some sort. The hormones that play a major role in 
female fertility are follicle stimulating hormone, luteinizing hormone, estrogen, progesterone and prolactin. 
Prolactin is a hormone  secreted by the pituitary gland. The pituitary gland is also known as the hypophysis, and 
is located just below the hypothalamus of the brain. Prolactin hormone is found in both men and women and is 
released at various times throughout the day and night. The role of prolactin is to stimulate milk production in 
pregnant women. It also enlarges a woman's mammary glands in order to allow her prepare for breastfeeding. It 
affects a woman’s ovulation and menstrual cycles, which is why women who are breastfeeding rarely get 
pregnant. Prolactin affects the above cycles by inhibiting the two hormones necessary for ovulation: follicle 
stimulating hormone (FSH) and gonadotropin releasing hormone (GnRH) (1). High levels of prolactin 
(hyperprolactinaemia) is one of the major causes of female infertility. Thus, this study seeks to evaluate the 
relationship between the prolactin hormone and female infertility rate among Abuja out-patients in National 
Hospital Abuja.  
 
II. Materials And Method 
The Materials used for this study include: records of female patients that visited National Hospital 
Abuja within the past 7 years on account of infertility, including their chemical pathology Immuno Assay forms. 
From these records, data on the prolactin hormone levels of the infertile women, type of infertility suffered and 
bio data of the women were obtained. 
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METHODOLOGY FOR DATA COLLECTION 
A Project proposal as well as an application for Ethical Approval of the study was drawn up and 
presented to the National Hospital Ethical Committee. The Ethical approval was granted and a senior registrar in 
the Obstetrics and Gynaecology department was assigned to supervise the study. 
With the assistance of the consulting physicians and the chemical pathology laboratory staff, the 
chemical pathology request forms of 32 randomly selected female infertility patients, were filled and their 
prolactin hormonal assay carried out. The data obtained from the chemical pathology request form included the 
following: Age, Sex, Ethnic group, Clinical summary, Last menstrual period, Usual duration of cycle, 
Diagnosis, Date sample was taken, Reproductive fertility hormone tests, Ovulatory serial profile, Thyroid 
function test, Pituitary function test, Adrenal function test, Tumour markers, Immunoglobulin  test, Dynamic 
function tests, Results of medical lab scientist, Pathologist’s report . However, the data relevant to our study 
from the above form were; Prolactin hormone level of the patients, the parity of the patients, the duration of the 
infertility problem, The type of infertility suffered by the patients. 
 
GROUPING PROTOCOL 
The 32 Patients were grouped into two based on the type of infertility they suffered; the two groups 
were those suffering from primary infertility and those suffering from secondary infertility. Group 1- Women 
suffering from Primary Infertility, while Group 2 – Women suffering from Secondary Infertility. 
 
STATISTICAL ANALYSIS 
Statistical analysis was carried out on the data obtained using the student T- test method and the results 
were presented in the form of tables and Bar Charts. 
 
III. Results 
The result obtained from the study carried out in National hospital was arranged in tables and 
interpreted using the T-test analytical tool. The data obtained consisted of sixteen women in each group. The 
women in Group one were mostly in their thirties and they had a mean prolactin level of 19.82ng/ml, which was 
greater than the mean of the normal prolactin level range- 15.50ng/ml. The women in group 2 were mostly in 
their thirties, and their mean prolactin level was 36.05ng/ml, which was also greater than the mean of the normal 
prolactin level range – 15.50ng/ml. 
On comparison of the prolactin levels in group one and in Group two, the student  t-test was used and a  
p value of ( 0.00004690) was obtained. This value indicates that the prolactin level difference between the 2 
groups was insignificant. It was observed that the higher the prolactin level, the lower the duration of infertility 
and vice versa.  
 
Table 1: Showing women with primary infertility 
PRIMARY INFERTILITY 
 
AGE(YEARS) PARITY 
PROLACTIN LEVEL 
( ng/ml) 
DURATION 
OF 
INFERTILITY duration in years 
 1 33 PO
+O 17.9 1 YEAR 1 
  2 22 PO
+O 4 4 YEARS 4 
  3 28 PO
+O 20.2 1 YEAR 1 
  
4 33 PO
+1 11.93 
3 YEARS 6 
MONTHS 3.5 
  5 32 PO
+O 17.8 3 YEARS  3 
  6 36 PO
+3 17.76 10 YEARS 10 
  7 37 PO
+1 11.4 10 MONTHS 0.8 
  8 35 PO
+O 14.3 3 YEARS 3 
  
9 41 PO
+1 14.75 4 YEARS 4 
  10 38 PO
+O 9.1 2 YEARS 2 
  11 46 PO
+O 26.9 3 YEARS 3 
  12 33 PO
+O 17.9 1 YEAR 1 
  13 39 PO
+O 101.5 3 YEARS 3 
  14 38 PO
+O 9.1 2 YEARS 2 
  15 34 PO
+O 16.4 1 YEAR 1 
  16 39 PO
+O 6.19 20 YEARS 20 
  Table 2: Showing women with primary infertility 
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IV. Discussion 
Table 1. represents the data of women suffering from primary infertility. About twelve of the patients 
under this category, were in their thirties’ and about twelve of the patients have never been pregnant. Altogether, 
there were sixteen patients under this category. The remaining four who had been pregnant previously, had not 
been able to carry their pregnancies up to 28 weeks (which is the age of viability in Africa), they had either 
suffered spontaneous abortion or voluntarily aborted their previous pregnancies. The relationship between the 
prolactin levels in the patients and the duration of infertility did not follow a regular pattern. However, all the 
patients under this category had prolactin levels that were within the normal range i.e 2 to 29ng/ml (10) except 
for one patient who had a prolactin level of 101.5ng/ml which is rather high for a non-pregnant woman. The 
patient with the longest duration of infertility (20years), had a prolactin level of 6.19ng/ml, which is at the lower 
limit of normal. The standard deviation was calculated and the mean value of the prolactin levels in the patients 
under this category was obtained. The mean value obtained was 19.82ng/ml, and it is higher than the mean value 
of the normal range which is 15.50ng/ml. Hence, these values correlate with the fact that raised prolactin level is 
associated with primary infertility. However, it was observed that there were high prolactin level, this pattern 
does not correlate with the fact that high levels of prolactin (hyperprolactinemia) is a significant cause of 
primary infertility because it affects both ovulation and the implantation of the embryo in the uterus(28). 
However, the fact that the women under this category married at different ages may have contributed to the 
pattern observed. Also, other factors other than prolactin levels may have contributed to the infertility suffered 
by these patients. Table 2. represents the data of female patients suffering secondary infertility. Nine of these 
patients were in their thirties, five in their twenties and two in their forties. All 16 of the patients had achieved 
pregnancy previously, though ten of them had either suffered miscarriages or been delivered of stillbirths. Six of 
them however, were successfully delivered of at least one pregnancy amidst miscarriages and stillbirths. The 
prolactin level in this category of patients, is mostly within the normal range except for two of them that were 
higher than normal (39.2 ng/ml and 306ng/ml), and one of them that was lower than normal (0.43ng/ml). The 
longest duration of infertility under this category is 11years. The relationship between the prolactin level and 
duration of infertility did not follow a regular pattern. The standard deviation for the prolactin levels of the 
women under the category secondary infertility was calculated and the mean also obtained (table 2). The mean 
value obtained (36.05ng/ml) was very much higher than the mean value of the normal range (15.50ng/ml). This 
however, does not correlate with the fact that prolactin levels in parous women is significantly lower than 
prolactin levels in nulliparous women (1). From the study carried out, a comparison of the effect of prolactin 
levels in the two categories of patients that is, primary infertility and secondary infertility, was carried out. The p 
value obtained from the student t-test (p<0.01), indicated that there was a significant difference in the prolactin 
levels between the women in group one and group two because the p value was less than 0.05. This significance 
does not correspond with the previous study that indicated that prolactin levels in parous women are 
significantly lower than prolactin levels in nulliparous women (3). 
 
V. Conclusion 
From the study carried out, it can be concluded that prolactin level abnormality was not the major cause 
of primary infertility, and that it was also not the major cause of secondary infertility among the infertile female 
patients in National hospital Abuja. 
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